ALTUVIIIO

NDC 71104-981 · Bioverativ Therapeutics Inc.

Generic nameAntihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl

Dosage formKIT

Marketing categoryBLA

Packages

71104-981-01 — 1 KIT in 1 KIT (71104-981-01) * 3 mL in 1 VIAL (71104-988-08) * 3 mL in 1 SYRINGE (71104-035-01)

Billed under HCPCS

J7214 — Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. Medicare Part B payment limit (ASP + 6%): $4.63

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels